RNA modifications are important regulators of gene expression. In 25
Trypanosoma brucei, transcription is polycistronic and thus most regulation 26 happens post-transcriptionally. N 6 -methyladenosine (m 6 A) has been detected in 27 this parasite, but its function remains unknown. Here we show that ~50% of the 28 m 6 A is located in the poly(A) tail of the monoallelically expressed Variant Surface 29
Glycoprotein (VSG) transcript. m 6 A residues are removed from the VSG poly(A) 30 tail prior to deadenylation and mRNA degradation. Using genetic tools, we 31 identified a 16-mer motif in the 3'UTR of VSG that acts as a cis-acting motif 32 required for inclusion of m 6 A in the poly(A) tail. Removal of this motif from the 33 VSG 3' UTR results in poly(A) tails lacking m 6 A, rapid deadenylation and mRNA 34 degradation. To our knowledge this is the first identification of an RNA 35 modification in the poly(A) tail of any eukaryote, uncovering a novel post-36 transcriptional mechanism of gene regulation. 37 38 39 Introduction 40 Trypanosoma brucei (T. brucei) is a protozoan unicellular parasite that 41 causes lethal diseases in sub-Saharan Africa: sleeping sickness in humans and 42 nagana in cattle 1 . In humans, the infection can last several months or years 43 mostly because T. brucei escapes the immune system by periodically changing 44 its variant surface glycoprotein (VSG) 2 . The T. brucei genome contains around 45
2000 antigenically distinct VSG genes, but only one VSG gene is actively 46 transcribed at a given time. Transcriptionally silent VSG genes are switched on 47 by homologous recombination into the BES or by transcriptional activation of a 48 new BES 2 , resulting in parasites covered by ~10 million identical copies of the 49 VSG protein 3 . 50 51 VSG is essential for the survival of bloodstream form parasites. VSG is not 52 only one of the most abundant proteins in T. brucei, but it is also the most 53 abundant mRNA in bloodstream forms (4-11% of total mRNA) 4,5 . VSG mRNA 54
abundance is a consequence of its unusual transcription by RNA polymerase I 55 and its prolonged stability. The half-life of VSG mRNA has been estimated to 56 range from 90-270 min, contrasting with the 12 min, on average, for other 57 transcripts 6 . The basis for its unusually high stability is not known. It is thought to 58 derive from the VSG 3'UTR, which contains two conserved motifs, a 9-mer and 59 a 16-mer motif, found immediately upstream of the poly(A) tail. Mutational studies 60 have shown that the 16-mer conserved motif is essential for VSG mRNA high 61 abundance and stability 7 , even though its underlying mechanism is unknown. 62 VSG expression is highly regulated when the bloodstream form parasites 63 undergo differentiation to the procyclic forms that proliferate in the insect vector 8 . 64
The BES becomes transcriptionally silenced and VSG mRNA becomes 65 unstable 9 , which results in rapid loss of VSG mRNA and replacement of the VSG 66 coat protein by other surface proteins (reviewed in 10 ). The mechanism by which 67 VSG mRNA becomes unstable during differentiation remain unknown. The 68 surface changes are accompanied by additional metabolic and morphological 69 adaptations, which allow procyclic forms to survive in a different environment in 70 the insect host 10 . 71 RNA modifications have been recently identified as important means of 72 regulating gene expression. The most abundant internal modified nucleotide in 73 eukaryotic mRNA is N 6 -methyladenosine (m 6 A) 11, 12 , which is widespread across 74 the human and mouse transcriptomes and is often found near stop codons and 75 the 3' untranslated regions of the mRNA encoded by multiple genes 13, 14 . m 6 A is 76 synthesized by a methyltransferase complex whose catalytic subunit, METTL3, 77 methylates adenosine in a specific consensus motif. Demethylases responsible 78 for removing m 6 A from mRNA have also been identified. m 6 A affects several 79 aspects of RNA biology, for instance contributing to mRNA stability, mRNA 80 translation, or affecting alternative polyadenylation site selection (reviewed in 15 ). 81 Here we show that N 6 -methyladenosine is an RNA modification enriched 82 in T. brucei mRNA. Importantly, this study revealed that m 6 A is present in mRNA 83 poly(A) tails, and half of m 6 A is located in only one transcript (VSG mRNA). We 84 identified a cis-acting element required for inclusion of m 6 A at the VSG poly (A)  85 tail and, by genetically manipulating this motif, we showed that m 6 A blocks 86 poly(A) deadenylation, hence promoting VSG mRNA stability. We provide the first 87 evidence that poly(A) tails of mRNA can be methylated in eukaryotes, playing a 88 regulatory role in the control of gene expression. 89 90
Results

92
m 6 A is present in T. brucei messenger RNA 93 94
To investigate if T. brucei RNA harbours modified nucleosides that could 95 play a role in gene regulation, we used liquid chromatography-tandem mass 96 spectrometry (LC-MS/MS) to detect possible modifications of RNA nucleosides. 97
Thirty seven possible modified nucleosides were found in total RNA (Table S1) , 98 most of which had been previously detected in T. brucei RNA including Am, which 99 is found in the mRNA cap structure, and m 3 C, m 5 C and Gm in tRNA and rRNA 16-100 18 . Mass-spectrometry analysis of mRNA revealed a clear peak that 101 corresponded to m 6 A. Given the importance of this modification for RNA 102 metabolism in other eukaryotes, we focused on this specific modification in T. 103
brucei.
104
First, we tested if m 6 A was mainly present in mRNA, or if it was present in 105 other type of RNA molecules (rRNA, tRNA and other non-coding RNAs). We also 106 compared two different stages of the parasite life cycle, the mammalian 107 bloodstream and the insect procyclic forms. An m 6 A nucleoside standard was 108 used as a control. The chromatograms of the poly(A)-enriched fraction (mRNA) 109 revealed a single peak corresponding to the 282à150 mass transition and an 110 elution time of 10 min ( Fig. 1A) , confirming it represents m 6 A. The chromatograms 111 of total RNA and poly(A)-depleted samples also contained a peak with an 112 identical mass transition, but the elution time was much earlier (6.5 min), which 113 likely reflects N 1 -methyladenosine (m 1 A), a modification with the same mass and 114 earlier elution times, and is commonly found in rRNAs and tRNAs 19, 20 . The m 6 A 115 peak in poly(A)-depleted RNA was barely detectable, indicating that most (if not 116 all) m 6 A is present in mRNA and absent from rRNA and tRNAs. Similar results 117
were obtained in RNA fractions obtained from the procyclic form insect stage 118 (Extended Data Fig. S1A ). 119 120
The m 6 A standard allowed us to quantify the abundance of m 6 A in both 121 stages of the life cycle (Extended Data Fig. S1B ). As expected, the levels are 122 very low in total and poly(A)-depleted fractions. In contrast, in both bloodstream 123 and procyclic forms mRNA fractions, m 6 A represents 0.06% of total adenines in 124 mRNA ( Fig. 1B) . In other words, 6 in 10,000 adenosines contain a methyl group 125 at position 6. This proportion is lower than in mammalian cells (0.1-0.4%, 11, 12 During their life cycle, parasites need to adapt to living in different 163 environments. The most recent studies have shown that around 30% of 164 transcripts and around 33-40% of proteins are differentially expressed between 165 these two life cycle stages 21, 22 . It is possible that m 6 A is not equally distributed 166 qualitatively and quantitatively in the transcripts of the two stages of the life cycle. 167
To test this hypothesis, performed immunoblotting with an antibody that 168 recognizes m 6 A. This antibody specifically recognizes m 6 A with minimal cross-169 reaction with unmodified adenosine or m 1 A (Extended Data Fig. S2 ). Mouse liver 170 total RNA was used as a control. As expected 13 , the immunoblotting of liver total 171
RNA revealed a smear in the entire lane, indicating that multiple RNA molecules 172 of different sizes harbour m 6 A ( Fig. 2A ). 173
Next, we examined m 6 A in total RNA, poly(A)-enriched and poly(A)-174
depleted RNAs derived from bloodstream and procyclic forms ( Fig. 2A ). 175
Consistent with the results obtained by LC-MS/MS, the poly(A)-depleted fraction 176 showed a weak m 6 A signal, revealing that m 6 A is absent or below detection levels 177
in rRNAs and tRNAs. In contrast, an m 6 A-positive smear was detected in poly(A)-178 enriched fraction both in bloodstream and procyclic forms, confirming that m 6 A is 179 present in multiple mRNA molecules in both stages of the life cycle. Strikingly, 180
however, the sample of bloodstream forms revealed an intense band of around 181
1.8 kb. This band accounts for ~50% of the m 6 A signal intensity in the lane (Fig.  182 2B), suggesting that m 6 A in bloodstream forms is highly enriched in one type or 183 several similarly sized types of transcripts. 184
The most abundant transcript in bloodstream forms is the VSG, which 185 accounts for ~5% of the total mRNA 5 . To test if the specific band is VSG, we 186 repeated the immunoblot assay but site-selectively cleaved the VSG transcript 187
with Ribonuclease H (RNase H) and monitored the mobility of the m 6 A band. 188
Poly(A) RNA was incubated with DNA oligonucleotides that annealed at different 189 sites along the length of the VSG transcript. RNase H digestion of the RNA:DNA 190 hybrids result in fragments of predicted sizes ( Fig. 2C-D ). If the VSG transcript is 191 the band with the intense m 6 A signal, the band detected by immunoblotting would 192
"shift" to one or two of the fragments of smaller size. 193 194 We first performed RNase H digestion of RNA pre-incubated without any 215 oligonucleotide or with a control oligonucleotide that annealed with a-tubulin 216
(another abundant transcript in T. brucei) did not affect the mobility of the m 6 A 217 band ( Fig. 2D ). Next, we used an oligonucleotide that hybridized to the spliced 218 leader (SL) sequence, a 39nt sequence that contains the mRNA cap and that is 219 added to every mRNA by a trans-splicing reaction 23 . RNase H digestion of RNA 220 pre-incubated with the SL oligonucleotide showed no effect on m 6 A 221 immunoblotting signal (Fig. 2D ). This indicates that m 6 A is neither present in 222 spliced leader sequence, nor in the mRNA cap structure. In contrast, when we 223 used oligonucleotides VSG-A, VSG-B and VSG-C, which hybridized to three 224 different unique sites in the VSG sequence ( Fig. 2C ), we observed that the major 225 m 6 A band shifted, and in all three conditions, the 3' end fragment contained the 226 entire m 6 A signal. Importantly, VSG-C oligonucleotide is adjacent the beginning 227 of the poly(A) tail. Thus, the 3' fragment released upon RNase H digestion with 228
VSG-C corresponds to the poly(A) tail of VSG mRNA. This fragment, which 229 contains the entire m 6 A signal from the VSG transcript, is heterogeneous in length 230
and shorter than 200 nt ( Fig. 2D ). 231
To further confirm that the 3' fragment released after incubation with VSG-232 C and RNase H corresponds to the VSG poly(A) tail, we performed RNase H 233 digestion in RNA pre-incubated with a poly(T) oligonucleotide. Consistent with 234 the results using VSG-C, the major band detected by m 6 A-antibody completely 235 disappears, further supporting the idea that in bloodstream forms most m 6 A is 236 present in the poly(A) tail of VSG mRNA. Interestingly, digestion of RNA 237 hybridized with poly(T), also abolished the smear detected by m 6 A-antibody, 238
indicating that m 6 A present in non-VSG transcripts is also most likely located in 239 their poly(A) tails. Notably, a similar approach to digest poly(A) tails does not 240 affect m 6 A levels in mammalian mRNA of HeLa cells 13 . Thus, this is the first 241 demonstration that a poly(A) tail can harbour a modified nucleotide. 242
Our results show that although VSG mRNA is only 4-11% of total mRNA, 243
it accounts for ~50% of cellular m 6 A, suggesting that VSG mRNA is preferentially 244 enriched in m 6 A compared to other mRNAs. Based on the m 6 A frequency in the 245 transcriptome and the enrichment in VSG, we estimate that there are nearly four 246 m 6 A molecules per VSG mRNA. In contrast, among the non-VSG mRNAs, only 247 one in five mRNAs are predicted to contain m 6 A. 248 249
Removing m 6 A precedes deadenylation and degradation of VSG transcript 250 251
The half-life of VSG transcript is 90-270 min, while the median mRNA half-252 life in trypanosomes is 13 min 6 . Given that removal of the poly(A) tail often 253 precedes RNA degradation, we hypothesized that the presence of m 6 A in the 254 poly(A) tail could account for this exceptional VSG mRNA stability. 255 We tracked m 6 A levels in VSG mRNA as it undergoes degradation in three 256 independent conditions. We first inhibited transcription in bloodstream form 257 parasites with actinomycin D (ActD) and, for the next 6 hours, we quantified the 258 amount of VSG mRNA that remains (by qRT-PCR). We also measured the levels 259 of m 6 A in VSG (by immunoblotting) and the length of the VSG poly(A) tail using 260 the Poly(A) Tail-Length Assay (PAT), which involves ligation of adaptors to the 3' 261 end of poly(A) tails and two consecutive PCRs using VSG-specific forward 262 primers (Fig. 3A) . The amplified fragments contain part of the ORF, the 3'UTR of 263 VSG transcript and the downstream poly(A) tail, whose size is variable between 264 different transcript molecules. 265
VSG mRNA has previously been shown to exhibit biphasic decay: in the 266 first hour after transcription blocking VSG mRNA levels remain high and, only in 267 a second phase, do VSG mRNA levels decay exponentially 9,24 . Consistent with 268 these earlier findings, we detected no major changes in mRNA abundance during 269
the first hour after actinomycin D treatment (lag phase, or first phase); however, 270
afterwards VSG exhibited exponential decay (second phase) ( Fig. 3B) while VSG mRNA only reached half of the steady-state levels around 2hr ( Fig.  280 3B). These results indicate that m 6 A is removed from VSG mRNA prior to the 281 deadenylation of the poly(A) tail, which is quickly and immediately followed by 282 degradation of the transcript. 283
When bloodstream form parasites undergo cellular differentiation to 284 procyclic forms, VSG is downregulated as a consequence of decreased 285 transcription and decreased mRNA stabilty 9 . To test whether m 6 A is also rapidly 286 removed from VSG mRNA prior to its developmentally programmed degradation, 287
we induced differentiation in vitro by adding cis-aconitate to the medium and 288
changing the temperature to 27ºC. Parasites were collected and total RNA was 289 extracted in different time points. Quantitative qRT-PCR showed that the levels 290
of VSG mRNA stayed stable for around one hour, which was followed by an 291 exponential decay ( Fig. 3D ). Importantly, immunoblotting analysis showed that 292 during parasite differentiation, m 6 A intensity in the VSG mRNA dropped faster 293 than the VSG-mRNA levels, reaching half of the steady-state levels in 23 min 294 ( Fig. 3D-E) . Thus, during parasite differentiation, we observed again that the 295 removal of m 6 A precedes the loss of VSG mRNA levels. 296
In addition to differentiation, another trigger for VSG mRNA degradation is 297 translation inhibition, which can be achieved by treating parasites with drugs such 298 as puromycin 25 . We treated bloodstream form parasites with puromycin and 299 collected RNA samples for 4 hours. Consistent with previous studies, qRT-PCR 300 revealed that VSG mRNA is actively degraded and it takes around 39 min to 301 reach half of steady state levels (Extended Data Fig. S3 ). Immunoblotting 302 revealed, once again, that m 6 A is removed earlier from the VSG transcript with a 303
half-life of about 10 min (Extended Data Fig. S3 ). 304
Overall, these results show that in three independent conditions, m 6 A is 305 removed from the VSG transcript earlier than the VSG transcript is deadenylated 306
and degraded, suggesting that m 6 A may need to be removed from the VSG 307 transcript before it can be degraded. 308 9 309 310 Inclusion of m 6 A in VSG mRNA is dependent on de novo transcription 330
In most organisms, m 6 A is generated by methylation of adenosine 331 residues within a specific consensus sequence by the METTL3 332 methyltransferase or its orthologs 15 . Given that in T. brucei, m 6 A is present in the 333 poly(A) tail, a different mechanism is likely used. Indeed, trypanosomes lack a 334 METTL3 ortholog 26 , indicating that a different pathway would be required to 335 acquire m 6 A in the poly(A) tail. To understand how m 6 A accumulates in the VSG 336 mRNA, we used parasite differentiation as a natural inducible system of VSG 337
downregulation. This process is reversible in the first two hours 27 . Parasite 338 differentiation was induced by adding cis-aconitate for 30 min (as described 339
above, Fig. 3D ), and then was washed away. As shown above, immunoblotting 340 revealed that m 6 A was reduced after 30 min of cis-aconitate treatment ( Fig. 4A-341 B, Fig. 3E ). In contrast, when cells were allowed to recover for 1 hr in the absence 342 of cis-aconitate or other drugs, we observed that the intensity of the m 6 A signal 343 returned to normal levels ( Fig. 4A-B) . These results indicate that, if differentiation 344 is halted and the levels of VSG mRNA are re-established (Extended Data Fig.  345 S4), VSG m 6 A is quickly recovered. 346
To test if the recovery of m 6 A levels after cis-aconitate removal was due 347
to de novo transcription, parasites were cultured in the presence of actinomycin 348 D . We observed that the intensity of m 6 A in theVSG transcript was not recovered. 349
Instead, the m 6 A levels decreased by ~20% ( Fig. 4A-B an antibody against m 6 A showed a punctate pattern both in the nucleus (20%) 356 and cytoplasm (80%) ( Fig. 4D-E ). To confirm that this m 6 A signal originated from 357 RNA, we incubated the fixed cells with nuclease P1 prior to the antibody staining, 358
which specifically cleaves single-stranded RNA without any sequence-specific 359 requirement. This treatment caused a marked reduction in the intensity of the 360 m 6 A signal, indicating that the immunoreactivity of the m 6 A antibody derives from 361 RNA, and not non-specific interactions with cellular proteins (Fig. 4C-D) . As an 362 additional control, we treated with actinomycin D for 2 hr prior to 363 immunofluorescence analysis. This treatment is expected to result in reduced 364 cellular mRNA levels. Immunostaining with the m 6 A antibody showed a drop in 365 the intensity of the m 6 A signal by around 40% (Fig. 4D-E) , which is similar to the 366 reduction observed by immunoblotting ( Fig. 3B-C) . Overall, these data support 367
the idea that the m 6 A immunostaining results likely reflect m 6 A in mRNA and not 368 a non-specific binding of the antibody to the cells. 
Inclusion of m 6 A in VSG poly(A) tail is dependent on neighboring cis-acting 394
motif 395 396 m 6 A is added to the VSG mRNA poly(A) tail soon after transcription, 397
probably still in the nucleus. m 6 A is not simply targeted to all poly(A) tails in the 398 cell since, if this were the case, all mRNAs would be methylated and VSG 399 methylation would only account for 4-11% of total cellular m 6 A. We therefore 400 asked how the VSG poly(A) tail is selected for preferential enrichment of m 6 A. It 401 has been previously shown that each VSG gene contains a conserved 16-mer 402 motif (5'-TGATATATTTTAACAC-3') in the 3'UTR adjacent to the poly(A) tail that 403 is necessary for VSG mRNA stability 7 . It has been proposed that a currently 404
unknown RNA-binding protein may bind this motif and stabilize the transcript by 405 an unknown mechanism 7 . Here, we hypothesized that this 16-mer motif may act 406
in cis to promote inclusion of m 6 A of the adjacent poly(A) tail. 407
To test the function of the 16-mer motif, we could not simply mutagenize 408 it because this would lead to an irreversible loss of VSG protein, which is lethal 409
for the parasites 7 . Therefore, we created two reporter cell-lines, in which a second 410
VSG gene (VSG117) was introduced in the active BES, from where VSG2 is 411 normally transcribed (Fig. 5A) . As a result, these reporter cell-lines are VSG 412 double-expressors, i.e. they simultaneously express VSG2 and VSG117 at the 413 cell surface. In the cell line designated "VSG double expressor 1", or "DE1", the 414 VSG117 gene contains the endogenous VSG2 3'UTR which harbors the 16-mer 415 motif. In the second cell-line, "VSG double expressor 2", or "DE2", VSG117 416 contains the same 3'UTR, except that the sequence of the 16-mer motif was 417 scrambled (5'-GTTATACAAAACTTTT-3') ( Fig. 5A ). As has been previously 418 reported, the transcript levels of VSG2 and VSG117 are dependent on each other 419 and are dependent on the presence of the 16-mer motif 7 . Quantitative RT-PCR 420 analysis showed that the two VSGs have roughly the same levels in DE1 cell-421 line. However, in DE2, VSG117 transcript is about 7-fold less abundant than 422 VSG2. (Fig. 5B, 5D ). 423
To test whether the 16-mer motif is required for inclusion of m 6 A in VSG 424 poly(A) tails, we performed m 6 A immunoblotting of cellular RNA obtained from 425 the two double-expressor cell lines. Given that VSG2 and VSG117 transcripts 426 have similar sizes (~1.8 kb), we used RNase H to selectively cleave VSG2 before 427 resolving the RNA on gel. VSG2 cleavage was performed by incubating the total 428
RNA sample with an oligonucleotide that hybridizes to the VSG2 open reading 429 frame, followed by incubation with RNase H (as described in Fig. 2) . As expected, 430 the VSG2-m 6 A-containing fragment is smaller and runs faster on gel (Fig. 5C ). 431
An "m6A index" was calculated by dividing the relative intensity of m 6 A in each 432
VSG band (Fig. 5C ) by the corresponding relative transcript levels measured by 433
qRT-PCR (Fig. 5B) . A low m 6 A index indicates a given transcript has fewer 434 modified nucleotides (Fig. 5D ). 435 436 437 438 is mutagenized (VSG117 with orange box in Fig. 5A ), the VSG m 6 A is 479 undetectable (Fig. 5C ), and the m 6 A index therefore is too low to calculate. These 480 results indicate that the motif is required for inclusion of m 6 A in the VSG transcript. 481
16-mer WT
16-mer MUT
TGATATATTTTAACAC GTTATACAAAACTTTT
In contrast, if the 16-mer motif played no role in m 6 A inclusion, the VSG117 482 m 6 A index would be identical in both cell-lines (DE1 and DE2), i.e. around 20. 483
Given that the qRT-PCR quantifications showed the relative intensity of VSG117 484 16-mer MUT is ~0.10 (Fig. 5B) , the predicted intensity of the VSG117 16-mer MUT 485 m 6 A band would have been 20 x 0.10= 2.0 arbitrary units. To be sure that a band 486
with this level of m 6 A would be detected on an immunoblot, we ran a more diluted 487 DE1 RNA sample in lane 3 (Fig. 5C ). The intensity of the VSG117 16-mer WT band 488 is 2.1 arbitrary units ( Fig. 5C and 5D ), and it is easily detected in the immunoblot. 489
Given that we could not detect any band corresponding to a putative methylated 490
VSG117 16-mer MUT in DE2 (even after over exposure of the immunoblot, 491
Extended Data Fig. S5 ), we conclude that the VSG conserved 16-mer motif is 492 necessary for inclusion of m 6 A in the VSG poly(A) tail. 493 494 m 6 A is required for VSG mRNA stability 495
The unusual localization of m 6 A in the poly(A) tail, and the lack of a 496 METTL3 ortholog, suggests that the underlying biochemistry of m 6 A formation in 497 trypanosomes is different from what has been described in other eukaryotes. 498
Given that, at this stage the mechanism of m 6 A formation in the poly(A) tail is 499 unknown and therefore cannot be directly blocked, we used the genetic mutants 500 of the 16-mer conserved motif to enquire about the function of m 6 A in VSG 501
mRNA. 502
To test the role of the 16-mer motif on poly(A) length on mRNA stability, 503
we measured VSG mRNA stability in 16-mer WT and 16-mer MUT cell-lines. VSG 504 mRNA half-life was measured by blocking transcription for 1 hr with actinomycin 505 D (the duration of the lag phase during VSG mRNA decay) and the levels of VSG 506 mRNA were followed by qRT-PCR. PAT assay clearly shows that, when the 507 VSG117 transcript contains the 16-mer motif (16-mer WT cell-line), the length of 508 the VSG117 poly(A) tail is stable for 1 hr (Fig. 6A-B) . In contrast, VSG117 509 transcripts containing a scrambled 16-mer motif exhibited very rapid shortening 510 of the poly(A) tail. In this case, there was no detectable lag phase-instead, the 511 length of the poly(A) tail was reduced to 25% of its original length after just 15 512 min, and was undetectable after 1 hr ( Fig. 6A-B) . Consistent with the fast kinetics 513 of poly(A) deadenylation, in the absence of an intact 16-mer motif, VSG117 514 transcript levels decayed very rapidly with a half-life of ~20 min (Fig. 6B ). 515
Overall, these experiments show that when the VSG conserved 16-mer 516 motif is mutated and the m 6 A is lost, the VSG transcript is no longer stable and 517 exhibits rapid poly(A) deadenylation and a marked reduction of mRNA stability. 
530
Discussion 531 532
In this work we report the identification and the function of the first RNA 533 epitranscriptomic modification in the poly(A) tail of mRNA. We show that the 534 stability and abundance of VSG transcripts stem from a novel mechanism in 535 which the presence of m 6 A in the poly(A) tail inhibits RNA degradation, probably 536 by blocking deadenylation. We also show that m 6 A is regulated by processes that 537 induce destabilization and degradation of VSG mRNA such as cellular 538 differentiation. 539
The classic function of a poly(A) tail is to keep mRNAs from being 540 degraded and to promote translation. Poly(A)-binding proteins (PABPs) bind the 541 poly(A) tail and stimulate mRNA translation by interaction with translation 542 initiation factors 28 . Removal of the poly(A) tail by deadenylase complexes (e.g. 543
Ccr4-Not complex) allow the unprotected mRNAs to enter in the 5´à3' or 544 3´à5´degradation pathways 29, 30 . In this report, we identified a novel mechanism 545 by which a poly(A) tail contributes to mRNA stability. We found that the poly (A)  546 tail of VSG, a transcript that represents 4-11% of mRNAs from T. brucei 547 bloodstream forms, contains half of the m 6 A present in the cell. Our estimates 548
suggest that each VSG poly(A) tail has around 4 modified adenosines. When we 549
measured VSG mRNA decay rates by treating with transcription-blocking drugs, 550
we found that m 6 A is removed from the VSG poly(A) tail before the tail is 551 deadenylated and mRNA is degraded, raising the possibility that m 6 A normally 552 prevents these processes. A similar observation was made during parasite 553 differentiation. The removal of m 6 A may therefore be the step that initiates 554 deadenylation and mRNA decay. To test this idea, we removed a 16-mer motif in 555 the 3'UTR, which we find is necessary for the inclusion of m 6 A in the VSG poly(A) 556 a DE- previous efforts from other labs have been unsuccessful at identifying proteins 577 that specifically bind to the 16-mer motif 7,32 . An alternative mechanism would be 578 if m 6 A is incorporated into the poly(A) tail while polymerisation takes place. If this 579 was true, there should be m 6 ATP inside the cell. Unbiased metabolomics 33 did 580 not support the existence of m 6 ATP, although studies specifically focused on 581 detecting this nucleotide would be required to completely disprove this model. 582
Deadenylation is the first step in the main mRNA decay pathway in 583 eukaryotes 34 . T. brucei is not an exception 23 . In this study we showed that m 6 A 584 seems to protect the poly(A) tail from deadenylation. The molecular mechanism 585 behind this stabilizing effect is unknown. It is possible that the deadenylases are 586 inefficient on a methylated poly(A) tail. There is structural and biochemical 587 evidence that poly(A) tails adopt a terciary structure that facilitates the recognition 588 by some deadenylases (CAF1 and Pan2) 35 . When a poly(A) tail contains m 6 A, 589 just like when it contains guanosines, the tertiary structure may be not properly 590 assembled and deadenylase activity is inhibited. In this model, a putative 591 demethylase may be required to remove the methyl group and only then poly(A) 592 tail would be deadenylated. Alternatively, the stabilizing effect of m 6 A could result 593 from recruitment of a specific RNA-binding protein, that prevents the poly(A) tail 594 from being deadenylated. 595 596
T. brucei has around 2000 VSG genes, but only one is actively transcribed 597 at a given time 2 . By a process of antigenic variation, parasites evade the host 598 immune response by changing an old VSG surface coat to a new VSG coat that 599 is antigenically distinct. m 6 A may be removed from VSG mRNA, facilitating the 600 switch from the old VSG mRNA, so that it can be more rapidly replaced by a new 601 VSG coat protein. Since m 6 A stabilizes the VSG mRNA, it will also be important 602 to determine whether inability to synthesize m 6 A in poly(A) tails results in more 603 frequent switching to new VSG coat proteins. The role of m 6 A in differentiation 604 remains to be established but it is possible that a delayed removal of VSG would 605
interfere with the interaction of the parasite with the midgut wall. 606
The Rudenko lab has proposed that the maximal amount of VSG mRNA 607 per cell is dependent on a post-transcriptional limiting factor dependent on the 608 presence of the 16-mer motif 7 . We propose that this limiting factor is the rate of 609 inclusion of m 6 A in the poly(A) tails. When the 16-mer motif is present in both 610
VSG genes, both get partially methylated and their abundance is reduced to 611 about half of a single-VSG expressor; however, when the 16-mer motif is absent 612 from one of the VSGs, the second VSG is more methylated and the transcripts 613 become more abundant. 614
As far as we know, our work describes the first RNA modification in poly(A) 615
tails. We show that m 6 A is present in the poly(A) tail of T. brucei mRNAs, it is 616 enriched in the most abundant transcript (VSG), and that m 6 A acts as a protecting 617 factor stabilizing VSG transcripts. It will be important for future studies to identify 618 the enzymes and proteins involved in adding, reading, or removing this RNA 619 modification. Given the importance of VSG regulation for chronic infection and 620 parasite transmission, drug targeting such enzymes is expected to result in an 621 important loss of parasite virulence. Understanding these regulatory 622
epitranscriptomic processes may open up possibilities for developing therapeutic 623 strategies to treat sleepiness sickness. 746  747  Figures S1 to S5  748  Tables S1 to S3  749  750 Lightning Plus-ECL, Enhanced Chemiluminescence Substrate kit (PerkinElmer 885 ref. NEL103E001EA). The percentage of m 6 A in the main "band" co-migrating 886 with the 2 kb molecular weight standard was measured by the intensity of the 887 "band" divided by the signal intensity of the whole lane. 888 889
Supplementary information
Estimation of m 6 A per VSG mRNA. 890
The number of m 6 A per VSG mRNA molecule was estimated based on the 891 enrichment of m 6 A 1) in the VSG transcript (0,06%), 2) on the fraction of m 6 A 892 present in VSG mRNA (0,50) and 3) on previously quantified parameters 893
(detailed below). The number of mRNAs per T. brucei bloodstream forms cell is 894 20 000 41 . The number of VSG mRNAs per cell is 1000 41 (assuming that 895 correspond to 5% of the mRNA). The average mRNA length is 2000 nt 42 . The 896 approximate length of the poly(A) tail is 100 nt 43 . The approximate frequency of 897 adenosine in the transcriptome is 0,25. 898 899
The number of adenosines per mRNA molecule correspond to: 
